A new analysis has suggested that an inflammatory response may be a crucial and modifiable determinant of disability accrual in progressive-onset multiple sclerosis.
Clyde E. Markowitz, MD, and Patricia K. Coyle, MD, provide insight on the 2017 revisions to the McDonald criteria that will optimize the management of patients with multiple sclerosis.

SAP Partner Banner

About NeurologyLive's Multiple Sclerosis Clinical Focus page:

The NeurologyLive Multiple Sclerosis Clinical Focus center offers the latest clinical news and expert insights related to this disabling disease of the central nervous system (CNS). Content found here includes video interviews with multiple sclerosis experts and key opinion leaders in neurology sharing insights on new and emerging therapies and management techniques, including insight and perspective novel treatment techniques. 

This page offers information regarding current strategies for multiple sclerosis treatment, as well as emerging therapeutic options for the disease being presented at major medical conferences and gaining traction in the scientific literature.